Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...
North America Holds a 44% Share, Viral Vectors and Gene Therapy Lead, and Asia Pacific Is the Fastest-Growing RegionOttawa, ...
The genetic medicine revolution is underway. Just 18 months ago, very few people in the general population had heard of mRNA vaccines; now, hundreds of millions globally have been vaccinated with one.
Many biotech and pharmaceutical companies focused on mRNA manufacturing experience challenges associated with their plasmid DNA (pDNA) supply, including slow or delayed production and poor or ...
Tech Times on MSN
Novartis confirms Zolgensma caused tumors in two children via gene therapy vector integration
Novartis confirms Zolgensma's viral vector caused tumors in two children via DNA integration - but the FDA label still calls the risk 'theoretical.' ...
HAMPTON, England--(BUSINESS WIRE)--Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) ...
Molecular cloning relies on two key components to construct recombinant DNA: 1) a DNA vector and 2) one or more DNA fragments containing the gene(s) of interest (GOI). To produce a GOI fragment, DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results